Women and Bleeding Disorders (WBD)

“Women and girls with bleeding disorders face numerous additional challenges, including monthly bleeding, pregnancy, and childbirth, that require better research and recognition, to bridge the significant gap in equitable care that we are striving to achieve across Europe.”

EHC WBD Committee

Aspect-based

About women and bleeding disorders

The WBD Committee of the EHC officially started in 2018. Since then, committee members meet every month to advance their cause: creating awareness, recognition, support, and education about and for women in the bleeding disorder community at the European level.

Bleeding disorders affect both men and women, with women often experiencing amplified symptoms during menstruation, childbirth, and perimenopause, including heavier and longer menstrual flows, increased pain, and a higher risk of haemorrhagic ovarian cysts and endometriosis. Due to the misconception that these disorders only affect men, many women remain undiagnosed and untreated.

To get involved or learn more about the WBD Committee, please contact Zita Gacser, Community and Projects Lead.

Join the Women and Bleeding Disorders Committee

We are currently looking for seven (7) volunteers to join the EHC’s Women and Bleeding Disorders Committee for a period of 3 years (2026-2028).

This committee has been established to create awareness, recognition, support and education about, and for, women in the bleeding disorder community at the European level. The committee provides advice to EHC members, volunteers and staff in matters concerning women with bleeding disorders.

Consult the call for applications via the following link: Call for Volunteers WBD 2026-2028

Applications should be sent to Zita Gacser by 4 January 2026 at the latest.

Note that these positions are open to members of EHC National Member Organisations (NMOs) or individuals who have a strong professional link with one of the EHC NMOs.

We would love to have you involved as we continue our work to improve the wellbeing of women with bleeding disorders.